Chemotherapy Infusion Pumps Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Chemotherapy infusion pumps are used to control drug dosages among patients that undergo chemotherapy treatment. The infusion pumps are attached to ports, catheters that are attached either inside or outside the patient’s body. These pumps helps to ease and speed up the reconstitution of chemotherapy drugs. The infusion pumps are also used by patients undergoing home chemotherapy. The chemotherapy infusion pumps are powered by electrical or mechanical stimulations and operate in different ways. These pumps are available in various types that includes syringe pumps, elastomeric pumps, smart pumps and others.
The growth of global chemotherapy infusion pumps market is expected to be majorly driven by increasing incidence of cancer across the world. Moreover, the development of application specific insulin pumps, development of smart pumps and government initiatives to promote safe usage of infusion pumps are additional factors expected to promote the growth of global chemotherapy infusion pumps market. Increasing focus on research and development to come up with products with reduced error rates and accurate delivery of insulin is expected to be a major opportunity for players in the global chemotherapy infusion pumps market.
The “Global Chemotherapy infusion pumps Market Analysis to 2028” is a specialized and in-depth study of the medical devices industry with a focus on the global market trend. The report aims to provide an overview of global chemotherapy infusion pumps market with detailed market segmentation by type, end user, and geography. The global chemotherapy infusion pumps market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global chemotherapy infusion pumps market is segmented on the basis of type and end user. On the basis of type, the global chemotherapy infusion pumps market is segmented into large volume pumps (LVP), syringe pumps, elastomeric pumps, and others. On the basis of end user, the global chemotherapy infusion pumps market is segmented in to hospitals & clinics and home care.
The chemotherapy infusion pumps market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global chemotherapy infusion pumps market based on type, and end user. It also provides market size and forecast till 2028 for overall chemotherapy infusion pumps market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America holds a dominant position in the global chemotherapy infusion pumps market which is attributed to the presence of major players in the region, high investment in research and healthcare, government initiatives for promotion of chemotherapy insulin pumps and others. Asia Pacific is expected to witness a significant growth over the forecast period owing to the increasing number patients suffering with several types of cancer as well as emergence of local players developing cost-efficient products in the region.
The chemotherapy infusion pumps market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The chemotherapy infusion pumps market report also includes the profiles of leading chemotherapy infusion pumps manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key developments in past five years. Some of the key players operating the global chemotherapy infusion pumps market include BD, ICU Medical, Inc., TERUMO COPORATION, B. Braun Melsungen AG, HYH, Smiths Group plc, Baxter, Frasenius Kabi AG, MOOG, INC., and Micrel Medical Devices SA among others.
![World Geography](https://www.theinsightpartners.com/assets/rdimages/world-geography.png)
Have a question?
![Analyst](https://www.theinsightpartners.com/assets/mrinal_kerhalkar.jpg)
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
![Analyst](https://www.theinsightpartners.com/assets/images/speak_analyst.gif)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
This text is related
to segments covered.
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
This text is related
to country scope.
Table of Contents
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. CHEMOTHERAPY INFUSION PUMPS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Chemotherapy Infusion Pumps Market - By Type
3.2.2. Chemotherapy Infusion Pumps Market - By End User
3.2.3. Chemotherapy Infusion Pumps Market - By Region
3.2.3.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. CHEMOTHERAPY INFUSION PUMPS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. CHEMOTHERAPY INFUSION PUMPS MARKET - GLOBAL ANALYSIS
5.1. GLOBAL CHEMOTHERAPY INFUSION PUMPS MARKET OVERVIEW
5.2. GLOBAL CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. EXPERT OPINIONS
6. CHEMOTHERAPY INFUSION PUMPS MARKET- GLOBAL REGULATORY SCENARIO
6.1. OVERVIEW
6.2. NORTH AMERICA
6.3. EUROPE
6.4. ASIA PACIFIC
6.5. MIDDLE EAST & AFRICA
6.6. SOUTH AND CENTRAL AMERICA
7. CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS TO 2028 - BY TYPE
7.1. OVERVIEW
7.2. TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. LARGE VOLUME PUMPS (LVP) MARKET
7.3.1. Overview
7.3.2. Large Volume Pumps (LVP) Market Revenue Forecasts and Analysis (US$ Mn)
7.4. SYRINGE PUMPS MARKET
7.4.1. Overview
7.4.2. Syringe Pumps Market Revenue Forecasts and Analysis (US$ Mn)
7.5. ELASTOMERIC PUMPS MARKET
7.5.1. Overview
7.5.2. Elastomeric Pumps Market Revenue Forecasts and Analysis (US$ Mn)
7.6. OTHERS MARKET
7.6.1. Overview
7.6.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
8. CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS TO 2028 - BY END USER
8.1. OVERVIEW
8.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. HOSPITALS & CLINICS MARKET
8.3.1. Overview
8.3.2. Hospitals & Clinics Market Revenue Forecasts and Analysis (US$ Mn)
8.4. HOME CARE MARKET
8.4.1. Overview
8.4.2. Home Care Market Revenue Forecasts and Analysis (US$ Mn)
9. NORTH AMERICA CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS TO 2028 - COUNTRY ANALYSIS
9.1. NORTH AMERICA CHEMOTHERAPY INFUSION PUMPS MARKET OVERVIEW
9.2. NORTH AMERICA CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. NORTH AMERICA CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
9.4. NORTH AMERICA CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.5. NORTH AMERICA CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.6. US MARKET OVERVIEW
9.6.1. US Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.6.2. US Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.7. CANADA MARKET OVERVIEW
9.7.1. Canada Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.7.2. Canada Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.8. MEXICO MARKET OVERVIEW
9.8.1. Mexico Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.8.2. Mexico Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10. EUROPE CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS TO 2028 - COUNTRY ANALYSIS
10.1. EUROPE CHEMOTHERAPY INFUSION PUMPS MARKET OVERVIEW
10.2. EUROPE CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. EUROPE CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
10.4. EUROPE CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.5. EUROPE CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.6. UK MARKET OVERVIEW
10.6.1. UK Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.6.2. UK Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.7. GERMANY MARKET OVERVIEW
10.7.1. Germany Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.7.2. Germany Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. FRANCE MARKET OVERVIEW
10.8.1. France Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.2. France Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11. ASIA PACIFIC CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS TO 2028 - COUNTRY ANALYSIS
11.1. ASIA PACIFIC CHEMOTHERAPY INFUSION PUMPS MARKET OVERVIEW
11.2. ASIA PACIFIC CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. ASIA PACIFIC CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
11.4. ASIA PACIFIC CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.5. ASIA PACIFIC CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.6. JAPAN MARKET OVERVIEW
11.6.1. Japan Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.6.2. Japan Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.7. CHINA MARKET OVERVIEW
11.7.1. China Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.7.2. China Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. INDIA MARKET OVERVIEW
11.8.1. India Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.8.2. India Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12. MIDDLE EAST AND AFRICA (MEA) CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS TO 2028 - COUNTRY ANALYSIS
12.1. MIDDLE EAST AND AFRICA CHEMOTHERAPY INFUSION PUMPS MARKET OVERVIEW
12.2. MIDDLE EAST AND AFRICA CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. MIDDLE EAST AND AFRICA CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
12.4. MIDDLE EAST AND AFRICA CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.5. MIDDLE EAST AND AFRICA CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.6. SOUTH AFRICA MARKET OVERVIEW
12.6.1. South Africa Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.6.2. South Africa Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.7. SAUDI ARABIA MARKET OVERVIEW
12.7.1. Saudi Arabia Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.7.2. Saudi Arabia Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.8. UAE MARKET OVERVIEW
12.8.1. UAE Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.8.2. UAE Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13. SOUTH AND CENTRAL AMERICA CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS TO 2028 - COUNTRY ANALYSIS
13.1. SOUTH AND CENTRAL AMERICA CHEMOTHERAPY INFUSION PUMPS MARKET OVERVIEW
13.2. SOUTH AND CENTRAL AMERICA CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. SOUTH AND CENTRAL AMERICA CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
13.4. SOUTH AND CENTRAL AMERICA CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.5. SOUTH AND CENTRAL AMERICA CHEMOTHERAPY INFUSION PUMPS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
13.6. BRAZIL MARKET OVERVIEW
13.6.1. Brazil Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.6.2. Brazil Chemotherapy Infusion Pumps Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14. INDUSTRY LANDSCAPE
14.1. ORGANIC GROWTH STRATEGIES
14.1.1. New Type Launches
14.1.2. Marketing & Promotional Activities
14.2. INORGANIC GROWTH STRATEGIES
14.2.1. Partnerships, Collaborations, and Joint Ventures
14.2.2. Mergers & Acquisitions
15. CHEMOTHERAPY INFUSION PUMPS MARKET, KEY COMPANY PROFILES
15.1. BD
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Type Portfolio
15.1.5. Type Pipeline
15.1.6. SWOT Analysis
15.1.7. Key Developments
15.2. ICU MEDICAL, INC.
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Type Portfolio
15.2.5. Type Pipeline
15.2.6. SWOT Analysis
15.2.7. Key Developments
15.3. TERUMO CORPORATION
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Type Portfolio
15.3.5. Type Pipeline
15.3.6. SWOT Analysis
15.3.7. Key Developments
15.4. B. BRAUN MELSUNGEN AG
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Type Portfolio
15.4.5. Type Pipeline
15.4.6. SWOT Analysis
15.4.7. Key Developments
15.5. HYH
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Type Portfolio
15.5.5. Type Pipeline
15.5.6. SWOT Analysis
15.5.7. Key Developments
15.6. SMITHS GROUP PLC
15.6.1. Business Description
15.6.2. Financial Overview
15.6.3. Type Portfolio
15.6.4. Type Pipeline
15.6.5. SWOT Analysis
15.6.6. Key Developments
15.7. BAXTER
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Type Portfolio
15.7.5. Type Pipeline
15.7.6. SWOT Analysis
15.7.7. Key Developments
15.8. FRASENIUS KABI AG
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Type Portfolio
15.8.5. Type Pipeline
15.8.6. SWOT Analysis
15.8.7. Key Developments
15.9. MOOG, INC.
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Type Portfolio
15.9.5. Type Pipeline
15.9.6. SWOT Analysis
15.9.7. Key Developments
15.10. MICREL MEDICAL DEVICES SA
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Type Portfolio
15.10.5. Type Pipeline
15.10.6. SWOT Analysis
15.10.7. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY
- BD
- ICU Medical, Inc.
- TERUMO COPORATION
- B. Braun Melsungen AG
- HYH
- Smiths Group plc
- Baxter
- Frasenius Kabi AG
- MOOG, INC.
- Micrel Medical Devices SA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.